{
    "Additional Indicators": [
        {
            "description": "Unfavorable Prognosis",
            "therapy": "NCCN, Consensus, Non-Small Cell Lung Cancer",
            "mutation": "KRASp.G12C Gain-of-function"
        }
    ],
    "Clinical trials": [
        {
            "description": "A Study of VS-6766 v. VS-6766 + Defactinib in Recurrent G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer ",
            "phase": "Phase 2",
            "mutations": [
                "KRAS"
            ]
        },
        {
            "description": "A Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1",
            "phase": "Phase 1/2",
            "mutations": [
                "KRAS",
                "STK11"
            ]
        },
        {
            "description": "First-in-human Study of DRP-104 (Sirpiglenastat) as Single Agent and in Combination With Atezolizumab in Patients With Advanced Solid Tumors. (NCT04471415)",
            "phase": "Phase 1/2",
            "mutations": [
                "NFE2L2",
                "STK11"
            ]
        }
    ],
    "variants of unknown significance": {
        "Somatic": [
            {
                "Gene": "NF1",
                "DNA Alteration": "c.4394A>G",
                "GeneMutation": "p.N1465S Nonsense-LOF",
                "VariantAlleleFraction": "2.37%"
            },
            {
                "Gene": "SDHA",
                "DNA Alteration": "c.1660C>T",
                "GeneMutation": "p.R554W Frameshift-LOF",
                "VariantAlleleFraction": "19.27%"
            },
            {
                "Gene": "RB1",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.F650S Frameshift-LOF",
                "VariantAlleleFraction": "1.17%"
            },
            {
                "Gene": "FGFR3",
                "DNA Alteration": "c.1138G>A",
                "GeneMutation": "p.S249C Frameshift-GOF",
                "VariantAlleleFraction": "5.27%"
            },
            {
                "Gene": "B2M",
                "DNA Alteration": "c.2T>G",
                "GeneMutation": "p.M1R Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "9.97%"
            },
            {
                "Gene": "JAK3",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.L857P Frameshift-GOF",
                "VariantAlleleFraction": "6.86%"
            },
            {
                "Gene": "FLT3",
                "DNA Alteration": "c.2028C>G",
                "GeneMutation": "p.V592G Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "8.89%"
            },
            {
                "Gene": "KLF1",
                "DNA Alteration": "c.892G>C",
                "GeneMutation": "p.M39L Nonsense-GOF",
                "VariantAlleleFraction": "9.67%"
            },
            {
                "Gene": "SDHD",
                "DNA Alteration": "c.34G>A",
                "GeneMutation": "p.G12S Stopgain-LOF",
                "VariantAlleleFraction": "7.45%"
            },
            {
                "Gene": "RB1",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.F650S Nonsense-GOF",
                "VariantAlleleFraction": "1.01%"
            },
            {
                "Gene": "HSD3B1",
                "DNA Alteration": "c.1100=",
                "GeneMutation": "p.T367= Frameshift-GOF",
                "VariantAlleleFraction": "1.94%"
            }
        ],
        "Germline": []
    }
}